Announcements

Yann Mazabraud, EVP and Head of International at Rhythm Pharmaceuticals, Inc., filed a Form 4 on August 14, 2026, disclosing a stock option exercise and the sale of common shares on August 12, 2026, all executed under a pre-established Rule 10b5-1 trading plan.

Jennifer Kayden Lee, Executive Vice President and Head of North America at Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM), filed a Form 4 on August 14, 2026, reporting stock option exercises and a same-day sale of common stock executed on August 13, 2026.

CoreWeave, Inc. Chief Operating Officer Sachin Jain filed a Form 4 on August 14, 2026, disclosing a sale of Class A Common Stock on August 12, 2026, pursuant to a pre-established Rule 10b5-1 trading plan.

Dara S. Redler, Chief Legal and Administrative Officer of H&R Block Inc, filed a Form 4 on August 14, 2026, reporting the acquisition of 17,271 shares of common stock on August 12, 2026, through the vesting of performance share units.

Corteva, Inc. filed a current report on August 14, 2026, disclosing that its subsidiary Vylor, Inc. submitted the first amendment to a Form 10 registration statement with the U.S. Securities and Exchange Commission in connection with Corteva's previously announced plan to separate its seed …

Quantum Corporation filed a Form 8-K on August 14, 2026, disclosing that Chief Accounting Officer and Principal Accounting Officer Laura A. Nash will transition out of her role effective September 1, 2026, with her employment expected to terminate on December 31, 2026.

Berto Acquisition Corp., a Cayman Islands-incorporated blank check company listed on NASDAQ:TACO, filed its Form 10-Q for the quarterly period ended June 30, 2026, with the SEC on August 14, 2026.